ZIVO Bioscience Enters into Exchange Agreements with Investors
On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]
ZIVO Bioscience Enters into Exchange Agreements with Investors
On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]
Leave a Reply
ZIVO Bioscience Enters into Exchange Agreements with Investors
On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]